238 related articles for article (PubMed ID: 16213470)
1. Lack of effects on core obsessive-compulsive symptoms of tryptophan depletion during symptom provocation in remitted obsessive-compulsive disorder patients.
Berney A; Sookman D; Leyton M; Young SN; Benkelfat C
Biol Psychiatry; 2006 May; 59(9):853-7. PubMed ID: 16213470
[TBL] [Abstract][Full Text] [Related]
2. Effects of tryptophan depletion on selective serotonin reuptake inhibitor-remitted patients with obsessive compulsive disorder.
Hood SD; Broyd A; Robinson H; Lee J; Hudaib AR; Hince DA
J Psychopharmacol; 2017 Dec; 31(12):1615-1623. PubMed ID: 29095069
[TBL] [Abstract][Full Text] [Related]
3. Effects of tryptophan depletion on cognitive functioning, obsessive-compulsive symptoms and mood in obsessive-compulsive disorder: preliminary results.
Külz AK; Meinzer S; Kopasz M; Voderholzer U
Neuropsychobiology; 2007; 56(2-3):127-31. PubMed ID: 18259085
[TBL] [Abstract][Full Text] [Related]
4. Tryptophan depletion in patients with obsessive-compulsive disorder who respond to serotonin reuptake inhibitors.
Barr LC; Goodman WK; McDougle CJ; Delgado PL; Heninger GR; Charney DS; Price LH
Arch Gen Psychiatry; 1994 Apr; 51(4):309-17. PubMed ID: 8161291
[TBL] [Abstract][Full Text] [Related]
5. Acute tryptophan depletion in depressed patients treated with a selective serotonin-noradrenalin reuptake inhibitor: augmentation of antidepressant response?
Booij L; Van der Does AJ; Haffmans PM; Riedel WJ
J Affect Disord; 2005 Jun; 86(2-3):305-11. PubMed ID: 15935252
[TBL] [Abstract][Full Text] [Related]
6. Effects of acute tryptophan depletion in serotonin reuptake inhibitor-remitted patients with generalized anxiety disorder.
Hood SD; Hince DA; Davies SJ; Argyropoulos S; Robinson H; Potokar J; Nutt DJ
Psychopharmacology (Berl); 2010 Feb; 208(2):223-32. PubMed ID: 19936713
[TBL] [Abstract][Full Text] [Related]
7. Mindfulness-based cognitive therapy in obsessive-compulsive disorder: protocol of a randomized controlled trial.
Külz AK; Landmann S; Cludius B; Hottenrott B; Rose N; Heidenreich T; Hertenstein E; Voderholzer U; Moritz S
BMC Psychiatry; 2014 Nov; 14():314. PubMed ID: 25403813
[TBL] [Abstract][Full Text] [Related]
8. Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis.
Issari Y; Jakubovski E; Bartley CA; Pittenger C; Bloch MH
J Clin Psychiatry; 2016 May; 77(5):e605-11. PubMed ID: 27249090
[TBL] [Abstract][Full Text] [Related]
9. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder.
Mataix-Cols D; Rauch SL; Manzo PA; Jenike MA; Baer L
Am J Psychiatry; 1999 Sep; 156(9):1409-16. PubMed ID: 10484953
[TBL] [Abstract][Full Text] [Related]
10. Cognitive-behavioral therapy as an adjunct to serotonin reuptake inhibitors in obsessive-compulsive disorder: an open trial.
Simpson HB; Gorfinkle KS; Liebowitz MR
J Clin Psychiatry; 1999 Sep; 60(9):584-90. PubMed ID: 10520976
[TBL] [Abstract][Full Text] [Related]
11. Double-blind, placebo-controlled trial of topiramate augmentation in treatment-resistant obsessive-compulsive disorder.
Berlin HA; Koran LM; Jenike MA; Shapira NA; Chaplin W; Pallanti S; Hollander E
J Clin Psychiatry; 2011 May; 72(5):716-21. PubMed ID: 20816027
[TBL] [Abstract][Full Text] [Related]
12. Serum cholesterol in patients with obsessive compulsive disorder during treatment with behavior therapy and SSRI or placebo.
Peter H; Tabrizian S; Hand I
Int J Psychiatry Med; 2000; 30(1):27-39. PubMed ID: 10900559
[TBL] [Abstract][Full Text] [Related]
13. Using acute tryptophan depletion to investigate predictors of treatment response in adolescents with major depressive disorder: study protocol for a randomised controlled trial.
Stewart RM; Hood SD; Rao P; Moore JK; Runions KC; Murphy SE; Wong JWY; Zepf FD
Trials; 2018 Aug; 19(1):434. PubMed ID: 30097056
[TBL] [Abstract][Full Text] [Related]
14. The putative catalytic role of higher serotonin bioavailability in the clinical response to exposure and response prevention in obsessive-compulsive disorder.
Sampaio T; Lima C; Corregiari F; Bernik M
Braz J Psychiatry; 2016; 38(4):287-293. PubMed ID: 27798711
[TBL] [Abstract][Full Text] [Related]
15. The effects of experimentally lowered serotonin function on emotional information processing and memory in remitted depressed patients.
Merens W; Booij L; Haffmans PJ; van der Does A
J Psychopharmacol; 2008 Aug; 22(6):653-62. PubMed ID: 18308809
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome in adults with obsessive-compulsive disorder.
Bloch MH; Green C; Kichuk SA; Dombrowski PA; Wasylink S; Billingslea E; Landeros-Weisenberger A; Kelmendi B; Goodman WK; Leckman JF; Coric V; Pittenger C
Depress Anxiety; 2013 Aug; 30(8):716-22. PubMed ID: 23532944
[TBL] [Abstract][Full Text] [Related]
17. The impact of trauma and post-traumatic stress disorder on the treatment response of patients with obsessive-compulsive disorder.
Shavitt RG; Valério C; Fossaluza V; da Silva EM; Cordeiro Q; Diniz JB; Belotto-Silva C; Cordioli AV; Mari J; Miguel EC
Eur Arch Psychiatry Clin Neurosci; 2010 Mar; 260(2):91-9. PubMed ID: 20077119
[TBL] [Abstract][Full Text] [Related]
18. Predictors associated with improved cognitive-behavioral therapy outcome in pediatric obsessive-compulsive disorder.
Torp NC; Dahl K; Skarphedinsson G; Compton S; Thomsen PH; Weidle B; Hybel K; Valderhaug R; Melin K; Nissen JB; Ivarsson T
J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):200-207.e1. PubMed ID: 25721185
[TBL] [Abstract][Full Text] [Related]
19. Phenomenological and pharmacological study of provoked obsessive/anxiety symptoms in obsessive-compulsive disorder: a preliminary study.
Kim SW; Dysken MW; Kushner MG; Kuskowski MA; Hoover KM; Klein KW; Faris PL; Hartman BK
Biol Psychiatry; 1997 Dec; 42(11):969-75. PubMed ID: 9386847
[TBL] [Abstract][Full Text] [Related]
20. Obsessive-compulsive disorder.
Bokor G; Anderson PD
J Pharm Pract; 2014 Apr; 27(2):116-30. PubMed ID: 24576790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
